Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors.

Warner RR, Curran T, Shafir MK, Schiano TD, Khaitova V, Kim MK.

Pancreas. 2011 May;40(4):622-6. doi: 10.1097/MPA.0b013e3182156c0b.

PMID:
21483253
[PubMed - indexed for MEDLINE]
2.

Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.

Namwongprom S, Wong FC, Tateishi U, Kim EE, Boonyaprapa S.

Ann Nucl Med. 2008 May;22(4):237-43. doi: 10.1007/s12149-007-0123-y. Epub 2008 Jun 6.

PMID:
18535873
[PubMed - indexed for MEDLINE]
3.

Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.

Korse CM, Bonfrer JM, Aaronson NK, Hart AA, Taal BG.

Neuroendocrinology. 2009;89(3):296-301. doi: 10.1159/000162876. Epub 2008 Oct 7.

PMID:
18840995
[PubMed - indexed for MEDLINE]
4.

Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.

Donica H, Malecha-Jędraszek A, Strosławska E, Burska A, Szubstarski F.

Folia Histochem Cytobiol. 2010 Dec;48(4):603-10. doi: 10.2478/v10042-010-0088-x.

PMID:
21478104
[PubMed - indexed for MEDLINE]
Free Article
5.

Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.

Korse CM, Taal BG, de Groot CA, Bakker RH, Bonfrer JM.

J Clin Oncol. 2009 Sep 10;27(26):4293-9. doi: 10.1200/JCO.2008.18.7047. Epub 2009 Aug 10.

PMID:
19667278
[PubMed - indexed for MEDLINE]
Free Article
6.

Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.

Belli SH, Oneto A, Aranda C, O'Connor JM, Domenichini E, Roca E, Méndez G, Bestani MC, Parma P, Giacomi N, Marmissolle F.

Acta Gastroenterol Latinoam. 2009 Sep;39(3):184-9.

PMID:
19845257
[PubMed - indexed for MEDLINE]
7.

Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.

Kidd M, Modlin IM, Mane SM, Camp RL, Shapiro MD.

Ann Surg. 2006 Feb;243(2):273-80.

PMID:
16432362
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?

Walter T, Chardon L, Chopin-laly X, Raverot V, Caffin AG, Chayvialle JA, Scoazec JY, Lombard-Bohas C.

Eur J Cancer. 2012 Aug;48(12):1766-73. doi: 10.1016/j.ejca.2011.11.005. Epub 2011 Nov 29.

PMID:
22133573
[PubMed - indexed for MEDLINE]
9.

Chromogranin A: is it a useful marker of neuroendocrine tumors?

Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, Tomassetti P.

J Clin Oncol. 2007 May 20;25(15):1967-73.

PMID:
17513802
[PubMed - indexed for MEDLINE]
Free Article
10.

Clinical usefulness of plasma chromogranin a in pancreatic neuroendocrine neoplasm.

Paik WH, Ryu JK, Song BJ, Kim J, Park JK, Kim YT, Yoon YB.

J Korean Med Sci. 2013 May;28(5):750-4. doi: 10.3346/jkms.2013.28.5.750. Epub 2013 May 2.

PMID:
23678268
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.

Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M.

Hepatogastroenterology. 2005 May-Jun;52(63):731-41.

PMID:
15966194
[PubMed - indexed for MEDLINE]
12.

[Usefulness of chromogranin A determination in the diagnosis of neuroendocrine neoplasia].

Militello C, Cannizzaro R, Pradella P, Volpin E, Spirch S, Buonadonna A, De Appollonia L, Rossi C, Sigon R, Cipresso S, Terranova O.

Chir Ital. 1999 Jan-Feb;51(1):45-51. Italian.

PMID:
10514916
[PubMed - indexed for MEDLINE]
13.

Processing-independent quantitation of chromogranin a in plasma from patients with neuroendocrine tumors and small-cell lung carcinomas.

Børglum T, Rehfeld JF, Drivsholm LB, Hilsted L.

Clin Chem. 2007 Mar;53(3):438-46. Epub 2007 Jan 26.

PMID:
17259235
[PubMed - indexed for MEDLINE]
Free Article
14.

[New diagnostic method in pulmonary carcinoid].

Csiszér E, Antus B, Himber G, Hertel K, Fillinger J.

Magy Onkol. 2007;51(3):225-8. Epub 2007 Oct 7. Hungarian.

PMID:
17922062
[PubMed - indexed for MEDLINE]
Free Article
15.

Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors.

Arnold R, Wilke A, Rinke A, Mayer C, Kann PH, Klose KJ, Scherag A, Hahmann M, Müller HH, Barth P.

Clin Gastroenterol Hepatol. 2008 Jul;6(7):820-7. doi: 10.1016/j.cgh.2008.02.052. Epub 2008 Jun 10.

PMID:
18547872
[PubMed - indexed for MEDLINE]
16.

Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.

Søndenaa K, Sen J, Heinle F, Fjetland L, Gudlaugsson E, Syversen U.

World J Surg. 2004 Sep;28(9):890-5.

PMID:
15593463
[PubMed - indexed for MEDLINE]
17.

Diagnostic value of tumor M2-pyruvate kinase in neuroendocrine tumors. A comparative study with chromogranin A.

Pezzilli R, Migliori M, Morselli-Labate AM, Campana D, Ventrucci M, Tomassetti P, Corinaldesi R.

Anticancer Res. 2003 May-Jun;23(3C):2969-72.

PMID:
12926146
[PubMed - indexed for MEDLINE]
18.

Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.

Seregni E, Ferrari L, Bajetta E, Martinetti A, Bombardieri E.

Ann Oncol. 2001;12 Suppl 2:S69-72.

PMID:
11762355
[PubMed - indexed for MEDLINE]
19.

Chromogranin A is a sensitive marker of progression or regression in ileo-cecal neuroendocrine tumors.

Jensen KH, Hilsted L, Jensen C, Mynster T, Rehfeld JF, Knigge U.

Scand J Gastroenterol. 2013 Jan;48(1):70-7. doi: 10.3109/00365521.2012.733953. Epub 2012 Oct 24.

PMID:
23094948
[PubMed - indexed for MEDLINE]
20.

Measurements of chromogranin B can serve as a complement to chromogranin A.

Stridsberg M, Eriksson B, Fellström B, Kristiansson G, Tiensuu Janson E.

Regul Pept. 2007 Mar 1;139(1-3):80-3. Epub 2006 Nov 20.

PMID:
17116339
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk